Immediately following the Diwali festivities, the central government has extended a major financial relief package to cancer patients across the country. Prices for a total of 137 anti-cancer drugs have been significantly reduced, making crucial treatments much more affordable. Following strict directives from the National Pharmaceutical Pricing Authority, these revised rates have officially come into effect starting today, November 9. With this substantial price reduction, medications that previously cost around 50,000 rupees will now be available to patients for roughly 25,000 rupees.
Eighty-five firms release revised drug rates
According to official details shared by the National Pharmaceutical Pricing Authority, a total of 85 pharmaceutical companies have rolled out revised pricing structures for 1,364 anti-cancer formulations. Under this comprehensive market intervention, the regulatory body has capped the trade margins for these essential therapies. Data indicates that prices for approximately 679 distinct brands have been slashed by more than 50 percent. Furthermore, certain specialized medications have witnessed maximum price reductions of up to 96.45 percent. Based on initial projections, an anti-cancer drug that previously cost one lakh rupees can now be purchased for a mere 4,000 rupees.
Annual savings projected in billions for families
This major policy intervention is expected to alleviate the heavy financial burden historically borne by cancer patients and their families. Official estimates released by the regulatory authority suggest that the aggregate reduction in drug prices will result in cumulative annual savings of approximately 3,540.38 crore rupees for patients nationwide. Additionally, comprehensive guidelines have been issued to empower patients, ensuring they remain informed about the discounted pricing structures and can verify their medication lists. Starting today, individuals can check the updated prices directly through the Pharma Sahi Daam application as well as the official website of the NPPA.
Strict action outlined against overcharging
Along with the revised pricing rollout, strict regulatory warnings have been issued to medical retailers and healthcare institutions. Guidelines explicitly state that no chemist, retail pharmacy, or hospital-attached medical shop is permitted to charge prices exceeding the newly established maximum retail price. If any establishment attempts to overcharge consumers, patients and caregivers are authorized to register formal grievances. Complaints regarding inflated pricing can be submitted directly through the Pharma Jan Samadhan portal or by reaching out to the dedicated NPPA helpline at 1800-111-255.
